| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1359382 | Bioorganic & Medicinal Chemistry Letters | 2014 | 5 Pages |
A series of metronidazole–thiazole derivatives has been designed, synthesized and evaluated as potential antibacterial inhibitors. All the synthesized compounds were determined by elemental analysis, 1H NMR and MS. They were also tested for antibacterial activity against Escherichia coli, Bacillus thuringiensis, Bacillus subtilis and Pseudomonas aeruginosa as well as for the inhibition to FabH. The results showed that compound 5e exhibited the most potent inhibitory activity against E. coli FabH with IC50 of 4.9 μM. Molecular modeling simulation studies were performed in order to predict the biological activity of proposed compounds. Toxicity assay of compounds 5a, 5b, 5d, 5e, 5g and 5i showed that they were noncytotoxic against human macrophage. The results revealed that these compounds offered remarkable viability.
Graphical abstractA series of metronidazole–thiazole derivatives has been designed, synthesized and evaluated as potential antibacterial inhibitors. The results showed that compound 5e exhibited the most potent Escherichia coli FabH inhibitory activity with IC50 of 4.9 μM.Figure optionsDownload full-size imageDownload as PowerPoint slide
